BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Loading...
Loading...

trophos.com Pages on BioPortfolio:

Trophos SA Receives Grant from The Michael J. Fox Foundation to ...
Trophos SA Receives Grant from The Michael J. Fox Foundation to Evaluate Compounds in Parkinson's Disease Model.
http://www.bioportfolio.com/biotech_news/Trophos_10.htm...

Trophos SA and CHDI, Inc. extend partnership to develop promising ...
Trophos SA and CHDI, Inc. extend partnership to develop promising compounds in models relevant to Huntington disease.
http://www.bioportfolio.com/biotech_news/Trophos_6.htm...

Trophos to present at American Academy of Neurology meeting
Rebecca Pruss, Chief Scientific Officer at Trophos, will present on the discovery and development of TRO19622: the company's lead drug candidate for the
...
http://www.bioportfolio.com/biotech_news/Trophos_3.htm...

BioPortfolio - Trophos SA - Profile
Trophos is a biopharmaceutical company committed to the discovery and development of novel ... Trophos has a fully integrated pre-clinical and
clinical ...
http://www.bioportfolio.com/biocorporate/31276-Trophos+SA.pd...

BioPortfolio - Trophos SA
Trophos SA - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/biocorporate/31276-Trophos_SA.ht...

Trophos starts Phase II Clinical Trial of TRO19622 in Liver Disease
15 May 2008 ... Trophos is a biopharmaceutical company committed to the discovery ... The Trophos discovery strategy has enabled it to develop a portfolio ...
http://www.bioportfolio.com/biotech_news/Trophos_12.htm...

Trophos strengthens management team with key appointments
New appointments in the Trophos product development team include the arrival of ... Dr Berna joins Trophos after successive positions in project management ...
http://www.bioportfolio.com/biotech_news/Trophos_2.htm...

Trophos successfully completes phase 1 clinical trials for novel ...
31 Jan 2006 ... Trophos successfully completes phase 1 clinical trials for novel compound to treat neurodegenerative diseases.
http://www.bioportfolio.com/biotech_news/Trophos_1.htm...

Trophos appoints Damian Marron as Chief Executive Officer
Marseille, June 12th, 2008 - Trophos SA, a biopharmaceutical company specializing in the discovery and development of drugs for neurological
disorders, ...
http://www.bioportfolio.com/biotech_news/Trophos_14.htm...

Trophos describes analgesic activity of neuroprotective agent ...
Trophos describes analgesic activity of neuroprotective agent TRO19622 in preclinical models of painful peripheral neuropathy.
http://www.bioportfolio.com/biotech_news/Trophos_13.htm...

Results from other life science and pharmaceutical sites:

Welcome to Trophos' homepage, drug discovery & development company ...
Trophos is a biopharmaceutical company developing drugs to prevent neuronal loss in patients with neurodegenerative disease.
http://www.trophos.com/...

BioPortfolio - Trophos SA
Trophos SA - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/biocorporate/31276-Trophos_SA.ht...

Trophos FAQs5
TRO19622 is a new chemical entity derived from the Trophos compound collection. ... Trophos is actively developing TRO19622 to treat patients with the motor ...
http://www.trophos.com/download/TrophosFaqs.pdf...

BioPortfolio - Trophos SA - Profile
Trophos is a biopharmaceutical company committed to the discovery and development of novel ... Trophos has a fully integrated pre-clinical and
clinical ...
http://www.bioportfolio.com/biocorporate/31276-Trophos%2BSA....

Corporate Fact Sheet – March 2007
In order to pursue the discovery programs in the chosen orphan indications Trophos has successfully obtained financial support ...
http://www.trophos.com/download/CorporateFactSheet.pdf...

Trophos starts Phase II Clinical Trial of TRO19622 in Liver Disease
15 May 2008 ... Trophos is a biopharmaceutical company committed to the discovery ... The Trophos discovery strategy has enabled it to develop a portfolio ...
http://www.bioportfolio.com/biotech_news/Trophos_12.htm...

Trophos: Press Archives
Trophos describes identification, characterization and broad neuroprotective properties of TRO19622 in Journal of Pharmacology and Experimental Therapeutics
...
http://www.trophos.com/news/prarchives.htm...

Trophos Completes Enrolment of Phase II Clinical Trial of TRO19622 ...
Marseille, June 5th, 2008 - Trophos SA, a biopharmaceutical company specializing in the discovery and development of drugs for neurological disorders, ...
http://www.biospace.com/news_story.aspx?NewsEntityId=99319...

Trophos: Contacts
Trophos' Head Office and Laboratories are located in Marseilles, France, on the Luminy campus of the Université de la Méditerranée. ...
http://www.trophos.com/people/contacts.htm...

Trophos strengthens management team with key appointments
New appointments in the Trophos product development team include the arrival of ... Dr Berna joins Trophos after successive positions in project management ...
http://www.bioportfolio.com/biotech_news/Trophos_2.htm...

Google Custom Search

Search
  

  Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2008 - BioPortfolio Limited.